Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-085 in Hypertriglyceridemia
NCT01350973Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2009
- Primary completion
- Dec 2010
01
Overview
Phase 3, randomised, double-blind trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia, sponsored by Takeda. Started Nov 2009; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT01350973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01350973.